Total Payments
$7,780
2024 Payments
$959.29
Companies
40
Transactions
492
Medicare Patients
14,073
Medicare Billing
$1.9M
Payment Breakdown by Category
Food & Beverage$7,773 (99.9%)
Education$6.97 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,773 | 491 | 99.9% |
| Education | $6.97 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,564 | 89 | $0 (2024) |
| Amgen Inc. | $746.91 | 55 | $0 (2024) |
| PFIZER INC. | $671.96 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $601.90 | 51 | $0 (2022) |
| Boston Scientific Corporation | $396.03 | 18 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $382.41 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $377.31 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $307.82 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $305.59 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $280.52 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.29 | 52 | Novartis Pharmaceuticals Corporation ($145.68) |
| 2023 | $806.44 | 48 | Amgen Inc. ($127.35) |
| 2022 | $761.27 | 45 | Novartis Pharmaceuticals Corporation ($212.38) |
| 2021 | $899.36 | 58 | Novartis Pharmaceuticals Corporation ($247.89) |
| 2020 | $625.05 | 39 | Amgen Inc. ($140.42) |
| 2019 | $1,373 | 78 | Novartis Pharmaceuticals Corporation ($263.04) |
| 2018 | $1,154 | 82 | Novartis Pharmaceuticals Corporation ($265.56) |
| 2017 | $1,201 | 90 | Novartis Pharmaceuticals Corporation ($172.15) |
All Payment Transactions
492 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: SYNERGY_IC | ||||||
| 12/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.84 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $45.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Obesity | ||||||
| 10/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Rheumatology | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Obesity | ||||||
| 09/11/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $66.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: SYNERGY_IC | ||||||
| 08/26/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: Not Applicable | ||||||
| 08/21/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: SYNERGY_IC | ||||||
| 08/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiology | ||||||
| 08/07/2024 | Boston Scientific Corporation | SYNERGY (Device) | Food and Beverage | In-kind items and services | $3.16 | General |
| Category: SYNERGY_IC | ||||||
| 08/02/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,435 | 5,066 | $989,855 | $469,222 |
| 2022 | 28 | 3,248 | 4,848 | $935,933 | $458,357 |
| 2021 | 35 | 3,796 | 5,525 | $1.1M | $544,853 |
| 2020 | 35 | 3,594 | 5,212 | $947,092 | $450,496 |
Total Patients
14,073
Total Services
20,651
Medicare Billing
$1.9M
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 51 | 51 | $148,869 | $93,837 | 63.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 572 | 868 | $111,972 | $71,314 | 63.7% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 58 | 58 | $94,830 | $62,686 | 66.1% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 108 | 216 | $78,840 | $50,585 | 64.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 213 | 214 | $69,336 | $28,556 | 41.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 148 | 592 | $51,800 | $22,634 | 43.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 131 | 350 | $30,800 | $21,028 | 68.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 294 | 313 | $101,412 | $16,203 | 16.0% |
| 78451 | Nuclear medicine study of heart muscle at rest and with stress and spect | Office | 2023 | 70 | 70 | $47,040 | $14,382 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $21,952 | $12,415 | 56.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 110 | 120 | $20,061 | $11,789 | 58.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 725 | 1,051 | $57,805 | $9,879 | 17.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 77 | 78 | $22,230 | $9,833 | 44.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 191 | 191 | $41,065 | $9,024 | 22.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 79 | 89 | $13,083 | $6,744 | 51.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 98 | $8,722 | $5,195 | 59.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $13,481 | $3,542 | 26.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 17 | 90 | $3,870 | $2,500 | 64.6% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 23 | 26 | $8,970 | $2,137 | 23.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 14 | 14 | $3,178 | $1,906 | 60.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 33 | $2,805 | $1,778 | 63.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $2,952 | $1,598 | 54.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 17 | 90 | $2,970 | $1,550 | 52.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 18 | 18 | $2,484 | $1,473 | 59.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $2,944 | $1,442 | 49.0% |
About Dr. William Schneider, MD
Dr. William Schneider, MD is a Cardiovascular Disease healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1902951270.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Schneider, MD has received a total of $7,780 in payments from pharmaceutical and medical device companies, with $959.29 received in 2024. These payments were reported across 492 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($7,773).
As a Medicare-enrolled provider, Schneider has provided services to 14,073 Medicare beneficiaries, totaling 20,651 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Huntsville, AL
- Active Since 01/24/2007
- Last Updated 07/18/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902951270
Products in Payments
- ENTRESTO (Drug) $1,276
- ELIQUIS (Drug) $723.52
- XARELTO (Drug) $601.90
- Repatha (Biological) $452.02
- LifeVest (Device) $382.41
- VERQUVO (Drug) $377.31
- Corlanor (Drug) $294.89
- LEQVIO (Drug) $286.41
- BRILINTA (Drug) $217.95
- JARDIANCE (Drug) $176.86
- MULTAQ (Drug) $171.95
- WATCHMAN (Device) $150.31
- SYNERGY (Device) $142.76
- ZIO XT Patch (Device) $140.88
- Ozempic (Drug) $136.19
- CHANTIX (Drug) $133.70
- PRALUENT (Drug) $133.64
- LEXISCAN (Drug) $110.81
- Kerendia (Drug) $105.29
- PRADAXA (Drug) $103.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Huntsville
Dr. Michael Butler, Md, MD
Cardiovascular Disease — Payments: $107,063
Cardiovascular Disease $107,063
Dr. Jay Dinerman, M.d, M.D
Cardiovascular Disease — Payments: $52,678
Cardiovascular Disease $52,678
Paul Tabereaux, Md, Mph, MD, MPH
Cardiovascular Disease — Payments: $38,822
Cardiovascular Disease $38,822
Dr. Enrique Velasquez, M.d, M.D
Cardiovascular Disease — Payments: $32,608
Cardiovascular Disease $32,608
Joshusa Valtos, Md, MD
Cardiovascular Disease — Payments: $21,858
Cardiovascular Disease $21,858
Dr. Sadasiva Katta, M.d, M.D
Cardiovascular Disease — Payments: $13,310
Cardiovascular Disease $13,310